Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17

1.

Long-Term Effects of Finasteride on Prostate Cancer Mortality.

Goodman PJ, Tangen CM, Darke AK, Lucia MS, Ford LG, Minasian LM, Parnes HL, LeBlanc ML, Thompson IM Jr.

N Engl J Med. 2019 Jan 24;380(4):393-394. doi: 10.1056/NEJMc1809961. No abstract available.

PMID:
30673548
2.

Continued Risk of Relapse Independent of Treatment Modality in Limited-Stage Diffuse Large B-Cell Lymphoma: Final and Long-Term Analysis of Southwest Oncology Group Study S8736.

Stephens DM, Li H, LeBlanc ML, Puvvada SD, Persky D, Friedberg JW, Smith SM.

J Clin Oncol. 2016 Sep 1;34(25):2997-3004. doi: 10.1200/JCO.2015.65.4582. Epub 2016 Jul 5.

3.

Design of phase I combination trials: recommendations of the Clinical Trial Design Task Force of the NCI Investigational Drug Steering Committee.

Paller CJ, Bradbury PA, Ivy SP, Seymour L, LoRusso PM, Baker L, Rubinstein L, Huang E, Collyar D, Groshen S, Reeves S, Ellis LM, Sargent DJ, Rosner GL, LeBlanc ML, Ratain MJ.

Clin Cancer Res. 2014 Aug 15;20(16):4210-7. doi: 10.1158/1078-0432.CCR-14-0521. Review.

4.

Plant science. Genomic-scale exchange of mRNA between a parasitic plant and its hosts.

Kim G, LeBlanc ML, Wafula EK, dePamphilis CW, Westwood JH.

Science. 2014 Aug 15;345(6198):808-11. doi: 10.1126/science.1253122.

5.

Genetic polymorphisms in oxidative stress-related genes are associated with outcomes following treatment for aggressive B-cell non-Hodgkin lymphoma.

Gustafson HL, Yao S, Goldman BH, Lee K, Spier CM, LeBlanc ML, Rimsza LM, Cerhan JR, Habermann TM, Link BK, Maurer MJ, Slager SL, Persky DO, Miller TP, Fisher RI, Ambrosone CB, Briehl MM.

Am J Hematol. 2014 Jun;89(6):639-45. doi: 10.1002/ajh.23709. Epub 2014 Apr 12.

6.

Optoperforation of single, intact Arabidopsis cells for uptake of extracellular dye-conjugated dextran.

LeBlanc ML, Merritt TR, McMillan J, Westwood JH, Khodaparast GA.

Opt Express. 2013 Jun 17;21(12):14662-73. doi: 10.1364/OE.21.014662.

PMID:
23787655
7.

Cure models as a useful statistical tool for analyzing survival.

Othus M, Barlogie B, Leblanc ML, Crowley JJ.

Clin Cancer Res. 2012 Jul 15;18(14):3731-6. doi: 10.1158/1078-0432.CCR-11-2859. Epub 2012 Jun 6.

8.

Distribution-free inference on contrasts of arbitrary summary measures of survival.

Rudser KD, LeBlanc ML, Emerson SS.

Stat Med. 2012 Jul 20;31(16):1722-37. doi: 10.1002/sim.4505. Epub 2012 Feb 23.

PMID:
22362470
9.

A strategy for full interrogation of prognostic gene expression patterns: exploring the biology of diffuse large B cell lymphoma.

Rimsza LM, Unger JM, Tome ME, Leblanc ML.

PLoS One. 2011;6(8):e22267. doi: 10.1371/journal.pone.0022267. Epub 2011 Aug 4.

10.

An appraisal of the fitness consequences of forest disturbance for wildlife using habitat selection theory.

Hodson J, Fortin D, Leblanc ML, BĂ©langer L.

Oecologia. 2010 Sep;164(1):73-86. doi: 10.1007/s00442-010-1691-4. Epub 2010 Jul 24.

PMID:
20658153
11.

Prognostic value of regulatory T cells, lymphoma-associated macrophages, and MUM-1 expression in follicular lymphoma treated before and after the introduction of monoclonal antibody therapy: a Southwest Oncology Group Study.

Sweetenham JW, Goldman B, LeBlanc ML, Cook JR, Tubbs RR, Press OW, Maloney DG, Fisher RI, Rimsza LM, Braziel RM, Hsi ED.

Ann Oncol. 2010 Jun;21(6):1196-202. doi: 10.1093/annonc/mdp460. Epub 2009 Oct 29.

12.

Gene expression predicts overall survival in paraffin-embedded tissues of diffuse large B-cell lymphoma treated with R-CHOP.

Rimsza LM, Leblanc ML, Unger JM, Miller TP, Grogan TM, Persky DO, Martel RR, Sabalos CM, Seligmann B, Braziel RM, Campo E, Rosenwald A, Connors JM, Sehn LH, Johnson N, Gascoyne RD.

Blood. 2008 Oct 15;112(8):3425-33. doi: 10.1182/blood-2008-02-137372. Epub 2008 Jun 10.

13.

Quantitative nuclease protection assay in paraffin-embedded tissue replicates prognostic microarray gene expression in diffuse large-B-cell lymphoma.

Roberts RA, Sabalos CM, LeBlanc ML, Martel RR, Frutiger YM, Unger JM, Botros IW, Rounseville MP, Seligmann BE, Miller TP, Grogan TM, Rimsza LM.

Lab Invest. 2007 Oct;87(10):979-97. Epub 2007 Aug 13.

14.

Dose-intense chemotherapy every 2 weeks with dose-intense cyclophosphamide, doxorubicin, vincristine, and prednisone may improve survival in intermediate- and high-grade lymphoma: a phase II study of the Southwest Oncology Group (SWOG 9349).

Blayney DW, LeBlanc ML, Grogan T, Gaynor ER, Chapman RA, Spiridonidis CH, Taylor SA, Bearman SI, Miller TP, Fisher RI; Southwest Oncology Group.

J Clin Oncol. 2003 Jul 1;21(13):2466-73.

PMID:
12829664
15.

Sequence analysis using logic regression.

Kooperberg C, Ruczinski I, LeBlanc ML, Hsu L.

Genet Epidemiol. 2001;21 Suppl 1:S626-31.

PMID:
11793751
16.

Systemic and regional hemodynamics after nitric oxide synthase inhibition: role of a neurogenic mechanism.

Huang M, Leblanc ML, Hester RL.

Am J Physiol. 1994 Jul;267(1 Pt 2):R84-8.

PMID:
7519412
17.

Hypermobility in psoriatic spondylitis.

LeBlanc ML, Bensen WG, Goldberg WM.

Arthritis Rheum. 1980 Jan;23(1):129-31. No abstract available.

PMID:
7352937

Supplemental Content

Loading ...
Support Center